The study investigates the role of the beclin 1 autophagy gene in tumor suppression. Beclin 1 is monoallelically deleted in a significant proportion of human breast, ovarian, and prostate cancers. Using a targeted mutant mouse model, the researchers tested the hypothesis that monoallelic deletion of beclin 1 promotes tumorigenesis. They found that heterozygous disruption of beclin 1 increases the frequency of spontaneous malignancies and accelerates the development of hepatitis B virus-induced premalignant lesions. Molecular analyses showed that the remaining wildtype allele is neither mutated nor silenced. Additionally, beclin 1 heterozygous disruption results in increased cellular proliferation and reduced autophagy in vivo. These findings demonstrate that beclin 1 is a haplo-insufficient tumor-suppressor gene and provide genetic evidence that autophagy is a novel mechanism of cell-growth control and tumor suppression. The study suggests that mutations in beclin 1 or other autophagy genes may contribute to the pathogenesis of human cancers. The research highlights the importance of autophagy in tumor suppression and provides insights into the genetic mechanisms underlying cancer development.The study investigates the role of the beclin 1 autophagy gene in tumor suppression. Beclin 1 is monoallelically deleted in a significant proportion of human breast, ovarian, and prostate cancers. Using a targeted mutant mouse model, the researchers tested the hypothesis that monoallelic deletion of beclin 1 promotes tumorigenesis. They found that heterozygous disruption of beclin 1 increases the frequency of spontaneous malignancies and accelerates the development of hepatitis B virus-induced premalignant lesions. Molecular analyses showed that the remaining wildtype allele is neither mutated nor silenced. Additionally, beclin 1 heterozygous disruption results in increased cellular proliferation and reduced autophagy in vivo. These findings demonstrate that beclin 1 is a haplo-insufficient tumor-suppressor gene and provide genetic evidence that autophagy is a novel mechanism of cell-growth control and tumor suppression. The study suggests that mutations in beclin 1 or other autophagy genes may contribute to the pathogenesis of human cancers. The research highlights the importance of autophagy in tumor suppression and provides insights into the genetic mechanisms underlying cancer development.